This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (39) Citing Articles via Google Scholar Google Scholar Articles by Poisal, J. A. Articles by Chulis, G. S. Search for Related Content PubMed PubMed Citation Articles by Poisal, J. A. Articles by Chulis, G. S. Related Collections Elderly Medicare Pharmaceuticals

Health Affairs, Vol 19, Issue 2, 248-256
Copyright © 2000 by Project HOPE

DataWatch

Medicare beneficiaries and drug coverage

Whether or not to add a prescription drug benefit to the basic Medicare package is at the forefront of congressional debate. Using data from the 1996 Medicare Current Beneficiary Survey (MCBS), we examine changes in drug insurance coverage levels from 1995 to 1996 and compare drug use and spending data for Medicare beneficiaries with and without drug coverage. The data show the enrollees without drug insurance consistently use fewer prescriptions, spend more out of pocket, and have less in total drug expenditures than their insured peers.

                      What's this?

This article has been cited by other articles:

				J. M. Madden, A. J. Graves, F. Zhang, A. S. Adams, B. A. Briesacher, D. Ross-Degnan, J. H. Gurwitz, M. Pierre-Jacques, D. G. Safran, G. S. Adler, et al. Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D JAMA, April 23, 2008; 299(16): 1922 - 1928. [Abstract] [Full Text] [PDF]

				P. Neuman, M. K. Strollo, S. Guterman, W. H. Rogers, A. Li, A. M. C. Rodday, and D. G. Safran Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors Health Aff., September 1, 2007; 26(5): w630 - w643. [Abstract] [Full Text] [PDF]

				C. Dai, R. S. Stafford, and G. C. Alexander National Trends in Cyclooxygenase-2 Inhibitor Use Since Market Release: Nonselective Diffusion of a Selectively Cost-effective Innovation Arch Intern Med, January 24, 2005; 165(2): 171 - 177. [Abstract] [Full Text] [PDF]